During the past decade, Centre Hospitalier d'Auxerre conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 2 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier d'Auxerre" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 12 trials, followed by "UNICANCER" with 8 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 6 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials sponsored and "ARCAGY/ GINECO GROUP" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier d'Auxerre" #1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Association Clinique Thérapeutique Infantile du val de Marne" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier d'Auxerre" are "Metastatic Colorectal Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Atrial Fibrillation" (2 trials), "Breast Cancer" (2 trials) and "Carcinoma, Non-Small-Cell Lung" (2 trials). Many other conditions were trialed in "Centre Hospitalier d'Auxerre" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier d'Auxerre" are "Drug" (28 trials), "Other" (12 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (4 trials), "fluorouracil" (3 trials), "Administration of the IPREA3 questionnaire" (2 trials), "Avelumab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier d'Auxerre" are 42 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier d'Auxerre". undefined are not yet recruiting, 12 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Centre Hospitalier d'Auxerre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier d'Auxerre, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".